Entyvio (Vedolizumab) - UHCprovider.com
Biologic DMARD [e.g., infliximab, Humira (adalimumab), Cimzia (certolizumab), Stelara (ustekinumab)] Janus kinase inhibitor [e.g., Xeljanz/Xeljanz XR (tofacitinib)] Tysabri (natalizumab) and Initial authorization will be for no more than 14 weeks. o …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Coverage Summary - UHCprovider.com Home
www.uhcprovider.comThe benefit information in this Coverage Summary is based on existing national coverage ... Also see the Medicare Prescription Drug Benefit Manual,Chapter 6, ...
Manual, Prescription, Drug, Benefits, Summary, Coverage, Prescription drug benefit manual, Coverage summary
UnitedHealthcare Group Medicare Advantage …
www.uhcprovider.comUnitedHealthcare® Group Medicare Advantage (PPO) Plan Network Care Provider Quick Reference Guide Insurance coverage provided by or through UnitedHealthcare Insurance Company or its affiliates.
Network, Reference, Medicare, Care, Group, Plan, Provider, Quick, Advantage, Unitedhealthcare, Unitedhealthcare group medicare advantage, 174 group medicare advantage, Plan network care provider quick reference
Shoulder Replacement Surgery (Arthroplasty)
www.uhcprovider.comShoulder Replacement Surgery (Arthroplasty) ... FDA-approved reverse shoulder replacement surgery devices are generally approved for gross rotator cuff deficiency. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional
Reserve, Replacement, Shoulder, Arthroplasty, Surgery, Reverse shoulder replacement, Shoulder replacement surgery
NEUROMUSCULAR ELECTRICAL STIMULATION …
www.uhcprovider.comNeuromuscular Electrical Stimulation (NMES) (NCD 160.12) Page 2 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 08/09/2017
Electrical, Stimulation, Neuromuscular, Neuromuscular electrical stimulation, Mens
APREPITANT FOR CHEMOTHERAPY-INDUCED …
www.uhcprovider.comChemotherapy-induced nausea and vomiting (CINV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy
Induced, Chemotherapy, Aprepitant, Nausea, Chemotherapy induced nausea and, Aprepitant for chemotherapy induced
Clinical Performance Guideline Medical Fertility Solutions ...
www.uhcprovider.comClinical Performance Guideline Fertility Solutions Infertility Medical Necessity Guideline Purpose: To provide an understanding of infertility treatment, issues surrounding infertility surgery, and issues surrounding multiple embryo transfers among individuals faced with the potential loss of fertility.
EXTRACORPOREAL SHOCK WAVE TREATMENT (ESWT)
www.uhcprovider.comExtracorporeal Shock Wave Treatment (ESWT) Page 1 of 4 ... Extracorporeal shock wave therapy (ESWT), using either a high- or low-dose protocol or a radial wave, is considered not medically necessary for all indications, including but not limited to the treatment of:
Treatment, Shocks, West, Therapy, Waves, Extracorporeal, Extracorporeal shock wave therapy, Extracorporeal shock wave treatment
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.comPervasive Developmental Disorder and Autism Spectrum Disorder: Benefit Interpretation Policy (Effective 01/01/2018) 3 Proprietary Information of UnitedHealthcare.
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.compervasive developmental disorders include autism, Rett's disorder, childhood disintegrative disorder, Asperger's disorder, and unspecified pervasive developmental disorder. E. …
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Approval Date: October 10, 2018 - UHCprovider.com Home
www.uhcprovider.comRetinal Prosthesis Page 1 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/10/2018 Proprietary Information of UnitedHealthcare.
Related documents
DRUG ADMINISTRATION CODING
www.cgsmedicare.comMar 03, 2016 · certolizumab pegol Cimzia® J0717 denosumab Prolia/Xygeva® J0897 golimumab Simponi® J3590 omalizumab Xolair® J2357 rilonacept Arcalyst® J2793 tocilizumab Actemra® J3262 ustekinumab Stelera® J3357 vedolizumab Entyvio® J3380
Administration, Coding, Drug, Cimzia, Drug administration coding
2018 Table of Drugs - CMS
www.cms.govFeb 15, 2018 · Cimzia, see Certolizumab pegol Cinacalcet ORAL J0604 Cinryze, see C1 Esterase Inhibitor Cipro IV, see Ciprofloxacin Ciprofloxacin 200 mg IV J0706 octic suspension 6 mg OTH J7342 Cisplatin, powder or solution per 10 mg IV J9060 Cladribine per …
Crohn s/Ulcerative Colitis Medication Request - Aetna
www.aetna.comCrohn’s/Ulcerative Colitis Medication Request Aetna Specialty Pharmacy ® 503 Sunport Lane Orlando, FL 32809 Customer Service: 1-866-782-ASRX (1-866-782-2779)
Specialty Medication Precertification Request
www.aetna.comSpecialty Medication Precertification Request Page 2 of 2 (All fields must be completed and legible for Precertification Review.) Aetna Precertification Notification
Aetna, Medication, Request, Specialty, Precertification, Specialty medication precertification request
Prior Authorization Program Information
www.bcbsfl.com* Important information on page 1 . Florida Blue is an Independent Licensee of the Blue Cross and Blue Shield Association Prior Authorization Program Information
Orencia Patient Information - BMS
packageinserts.bms.com• have any kind of infection even if it is small (such as an open cut or sore), or an infection that is in your whole body (such as the flu). If you have an infection when taking ORENCIA, you may have a higher